Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1997-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.41.5.1175PMID 9145895PMCID PMC163876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.

  2020cited by this paper
• GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

  1997cited by this paper
• Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity

  1996cited by this paper
• Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.

  1995cited by this paper
• A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis

  1994cited by this paper
• Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

  1994cited by this paper
• Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.

  1994cited by this paper
• Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.

  1994cited by this paper
• Streptococcal and enterococcal bacteremia in patients with cancer.

  1992cited by this paper
• Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis.

  1992cited by this paper
• Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.

  1992cited by this paper
• Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever—Reply

  1991cited by this paper
• Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.

  1991cited by this paper
• Viridans streptococcal bacteraemia in patients with haematological and solid malignancies.

  1991cited by this paper
• Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.

  1991cited by this paper
• Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.

  1991cited by this paper
• Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases

  1990cited by this paper
• The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients.

  1990cited by this paper
• From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.

  1990cited by this paper
• Bacteremia due to gram-positive cocci in patients with neoplastic disease.

  1979cited by this paper

• Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5‐azacitidine

  2017cites this paper
• Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials.

  2014cites this paper
• Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

  2012cites this paper
• The role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experience

  2011cites this paper
• Prevention and treatment of infections in patients with haematological malignancies

  2008cites this paper
• Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.

  2007cites this paper
• Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.

  2006cites this paper
• Management of febrile neutropenia

  2006cites this paper
• Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre

  2005cites this paper
• Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients

  2005cites this paper
• Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre: Rational approach towards the patient with cancer, fever and neutropenia

  2005cites this paper
• Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

  2005cites this paper
• Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group

  2004cites this paper
• Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group

  2004cites this paper
• Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.

  2003cites this paper
• Epidemiology of febrile neutropenia.

  2003cites this paper
• The role of fluoroquinolones in the therapy and prophylaxis of neutropenic patients with cancer

  2003cites this paper
• Selective Bowel Decontamination for the Prevention of Infection in Acute Myelogenous Leukemia: A Prospective Randomized Trial

  2002cites this paper
• Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

  2002cites this paper
• Infections following hematopoietic stem cell transplantation.

  2001cites this paper
• Rifampin D oes N ot I mprove t he E fficacy o f Q uinolone Antibacterial P rophylaxis i n N eutropenic C ancer P atients: Results o f a R andomized C linical T rial

  2000cites this paper
• Use of the Quinolones in Immunocompromised Patients

  2000cites this paper
• Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.

  2000cites this paper
• Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.

  1999cites this paper